## ARM: Arm Holdings plc - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -2.9% below STRENGTH zone (4.0-10.0%); PEG 2.75 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($124.56)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Buys New Position in ARM Holdings PLC Sponsored ADR $ARM**
- Source: MarketBeat | 20251209T140930 | Bullish | Relevance: 98%
-  Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna has acquired a new stake of 17,335 shares in ARM Holdings PLC Sponsored ADR (NASDAQ:ARM) during the second quarter, valued at approximately $2.8 million. This makes ARM its 23rd largest holding, comprising about 1.1% of their portfolio. ARM reported strong Q2 earnings, beating expectations with $0.39 EPS and revenue of $1.14 billion, and analyst sentiment remains largely positive with a "Moderate Buy" consensus rating.

**2. Axa S.A. Acquires 207,894 Shares of ARM Holdings PLC Sponsored ADR $ARM**
- Source: MarketBeat | 20251209T080930 | Somewhat-Bullish | Relevance: 98%
-  Axa S.A. significantly increased its stake in ARM Holdings PLC by 49.3% in the second quarter, acquiring an additional 207,894 shares. Other institutional investors like Sustainable Growth Advisers LP and Schroder Investment Management Group also substantially boosted their holdings in ARM. The company recently reported strong quarterly earnings, topping analyst expectations, and several analysts have reiterated "buy" ratings with price target increases for ARM stock.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Loop Capital | $180 | $155 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Loop Capital | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 2.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Capital World Invest: 0.4% (-3.5%)
- Dz Bank Ag Deutsche : 0.4% (+1.5%)
- Morgan Stanley: 0.3% (-1.0%)
- Goldman Sachs Group : 0.3% (-7.0%)
- Sustainable Growth A: 0.3% (-16.7%)

### Key Risks

1. High beta (4.25) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Premium valuation (P/E 60x, PEG 2.8x) vulnerable to multiple compression.
3. Elevated short interest (10.3%): bears positioning against stock.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.75 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Balance sheet: strong liquidity (5.6x), low leverage (D/E 0.31). Revenue growth strong at 21% YoY. Analyst sentiment positive (1 raises, avg +16%). Institutional flow bullish (3 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $144.4B |
| Beta | 4.25 |
| 52W Range | $80.00 - $183.16 |
| Short Interest | 10.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.75 |
| Forward P/E | 60.0 |
| Current P/E | 79.2 |
| YoY Growth | 32.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.0% to -2.9% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.9pp (needs >4.0% for momentum thesis). Underperforming sector by 4.0pp, stock-specific weakness. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram positive (1.21), confirming momentum. RSI neutral at 40.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.87% (CS: 24) | Weak |
| RSI_14 | 40.2 | Neutral |
| MACD Histogram | 1.21 | Bullish |
| vs SMA20 | 0.992x | Below |
| vs SMA50 | 0.889x | Below |
| vs SMA200 | 0.988x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $136.14
- **Stop Loss:** $124.56 (8.5% risk)
- **Target:** $147.72 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 119
- **Position Value:** $16,200.66
- **Portfolio %:** 16.20%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-04 (Est: $0.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.39 | +17.7% |
| 2025Q2 | $0.35 | $0.35 | -0.3% |
| 2025Q1 | $0.52 | $0.55 | +5.0% |
| 2024Q4 | $0.34 | $0.39 | +14.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*